In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01250232PMID 2968439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum

  2005cited by this paper
• Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

  2004cited by this paper
• Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

  2004cited by this paper
• Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase

  2004cited by this paper
• D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.

  1986cited by this paper
• Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo

  1986cited by this paper
• The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.

  1986cited by this paper
• Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.

  1986cited by this paper
• Central dopaminergic properties of HW-165 and its enantiomers; Trans-octahydrobenzo(f)quinoline congeners of 3-PPP

  1986cited by this paper
• S(−)DP-5,6-ADTN as an in vivo dopamine receptor ligand: Relation between displacement by dopamine agonists and their pharmacological effects

  1986influential reference
• Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.

  1986cited by this paper
• Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation.

  1986cited by this paper
• SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.

  1986cited by this paper
• Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.

  1986cited by this paper
• TL 333, a benzhydro[g]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptor.

  1985cited by this paper
• SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.

  1985cited by this paper
• Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra.

  1985cited by this paper
• SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.

  1985cited by this paper
• Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.

  1985cited by this paper
• SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro

  1984cited by this paper
• N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists.

  1984cited by this paper
• SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.

  1984cited by this paper
• Two dopamine receptors: biochemistry, physiology and pharmacology.

  1984cited by this paper
• Dopamine receptor agonists neuropharmacological and bionanalytical evaluation

  1984influential reference
• Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

  1984influential reference
• Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.

  1984cited by this paper
• On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. With particular reference to dopaminergic mechanisms in the central nervous system.

  1983cited by this paper
• In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.

  1983cited by this paper
• Diastolic properties of the hypertrophied left ventricle in spontaneously hypertensive rats.

  1983cited by this paper
• In vivo dopamine receptor agonist binding in rat brain: relation with pharmacological effects.

  1983cited by this paper
• Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.

  1983influential reference
• SCH 23390 - the first selective dopamine D-1 antagonist.

  1983cited by this paper
• Behavioral correlations of dopamine receptor activation

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983influential reference
• Brain dopamine receptors.

  1980cited by this paper
• Regulation of Monoamine Synthesis and Utilization by Receptors

  1980cited by this paper
• Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents.

  1979cited by this paper
• MECHANISM OF ACTION OF NEUROLEPTIC DRUGS

  1978cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper
• 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo

  1976cited by this paper

• Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice

  2024influential citation
• Dopaminergic Modulation of Basal Forebrain Cholinergic Neurons

  2021cites this paper
• Reduced Threshold for Induction of LTP by Activation of Dopamine D1/D5 Receptors at Hippocampal CA1–Subiculum Synapses

  2013cites this paper
• The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3.

  2012cites this paper
• Dopamine D1/D5 Receptors Contribute to De Novo Hippocampal LTD Mediated by Novel Spatial Exploration or Locus Coeruleus Activity

  2011cites this paper
• Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.

  2010cites this paper
• Regulation of Akt and Wnt signalling by the dopamine D2 receptor and metabotropic glutamate receptor 2/3

  2010cites this paper
• Activation of dopamine D1/D5 receptors facilitates the induction of presynaptic long‐term potentiation at hippocampal output synapses

  2010cites this paper
• Genetic variance contributes to dopamine receptor antagonist-induced inhibition of sucrose intake in inbred and outbred mouse strains.

  2009cites this paper
• DOPAMINERGIC MODULATION OF RISK-BASED DECISION MAKING

  2008cites this paper
• Dopamine D1/D5 Receptors Gate the Acquisition of Novel Information through Hippocampal Long-Term Potentiation and Long-Term Depression

  2006cites this paper
• Le test-retest dans un modèle animal d'anxiété chez la souris : sensibilisation, discrimination dans le test des quatre-plaques

  2006cites this paper
• Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration

  2005cites this paper
• Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D 1 and D2 receptors and to axotomy

  2005cites this paper
• Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

  2005cites this paper
• Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine

  2005cites this paper
• Dopamine‐dependent and dopamine‐independent actions of cocaine as revealed by brain thermorecording in freely moving rats

  2005cites this paper
• Le test-retest dans un modèle animal d'anxiété chez la souris : sensibilisation, discrimination dans le test des quatre-plaques

  2005cites this paper
• Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity

  2004cites this paper
• In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion

  2004cites this paper
• Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration

  2004cites this paper
• Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.

  2003cites this paper
• Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat

  2001cites this paper
• Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.

  2001cites this paper
• SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons

  2000cites this paper
• Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo

  2000cites this paper
• Striatal Neuronal Activity and Responsiveness to Dopamine and Glutamate after Selective Blockade of D1 and D2 Dopamine Receptors in Freely Moving Rats

  1999cites this paper
• In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission.

  1996cites this paper
• The analeptic effect of methamphetamine in pentobarbital-narcotized rats is mediated via a dopaminergic-cholinergic mechanism.

  1994cites this paper
• Selective Effects of Low-Dose D2 Dopamine Receptor Antagonism in a Reaction-Time Task in Rats

  1993cites this paper
• The effects of SCH 23390 and raclopride on cocaine-induced analepsis and EEG arousal in rabbits.

  1993cites this paper
• Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system.

  1993cites this paper
• Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.

  1991cites this paper
• Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.

  1991cites this paper
• PET studies of the dopaminergic system. A review.

  1990cites this paper
• Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.

  1990cites this paper
• A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

  1990cites this paper
• Microstructural analysis of the anorectic effect of N-0437, a highly selective dopamine D2 agonist.

  1989cites this paper
• Pharmacological activity profiles of dopamine D-1 and D-2 reception agonists and antagonists on striatal neuronal activity and the response to dexamphetamine in freely moving rats.

  1989cites this paper
• The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice.

  1989cites this paper
• NSD 1034: An amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors

  1988cites this paper
• Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.

  1988cites this paper
• Behavioral/systems/cognitive Dopamine D 1 /d 5 Receptors Gate the Acquisition of Novel Information through Hippocampal Long-term Potentiation and Long-term Depression

  year unknowncites this paper